entertainment -WSS

entertainment

author：focus 2025-09-30 21:07:33 - browse：397

Emma Walmsley on stage at the 2023 STAT Summit. — GSK CEO Emma Walmsley at the 2023 STAT Summit. STAT

The story of GSK is one of reinvention, CEO Emma Walmsley said at the STAT Summit in Boston on Thursday. Having shed its consumer division, the British drug giant is writing a new chapter as a pure-play biopharma company dedicated to the prevention, as well as treatment, of disease.

GSK’s recent launch of a new RSV vaccine for adults is emblematic of this move, adding to a portfolio that includes other vaccines, such as the very successful Shingrix for shingles, as well as drugs for HIV, other infectious diseases, and cancer, among others. But what does the growing sentiment against vaccination, not just in the United States but around the world, mean for such a bet on this market?

“It’s a very, very serious issue,” Walmsley said, noting that in 11 U.S. states, basic vaccination rates are now lower than they were before Covid. “The answer can’t be sort of flinging science over the airwaves and saying ‘trust us,’ because people don’t. There is a really serious challenge of misinformation and the ongoing issue of politicization, which I suspect is going to get more challenging in the next year for obvious reasons.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

WSS

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

What AAP's gender

How Long Island became the ‘eugenics capital of the world’

Police still searching for prisoner who escaped from NYC hospital

Why more medical students aren't specializing in primary care

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

knowledge

entertainment

entertainment

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

How to make Best Hospitals ratings actually useful for patients

Malaria cases in Florida and Texas: Here’s what you need to know

Medicare explains how it will choose drugs for negotiation

Medical leaders decry Supreme Court decision on affirmative action

Psilocybin's anti

Hollywood unions extend contract negotiations for actors

Psilocybin's anti

After affirmative action ruling, medical educators look to 'holistic review'

Amylyx's ALS drug launch starts strong. It could be trouble for FDA

focus

Police still searching for prisoner who escaped from NYC hospital

AstraZeneca challenges Medicare drug negotiation program

Police still searching for prisoner who escaped from NYC hospital

AstraZeneca bets AAV gene therapy will still deliver the goods

NIH trials fail to test meaningful long Covid therapies, experts say

Drastic changes should bring profitability, startup health insurers say

leisure time

focus

focus

explore